13F filer · CIK 902219 ↗
Wellington Management Group LLP
You are looking at Q1 2025. See the latest, Q2 2026 →
Reported value
$519.87B
−4.8% on the quarter before
Positions
1,933
171 new · 165 sold out
Top 10
23.4%
of the value
Est. gain
−$17.31B
on stocks held all quarter
Est. return
−3.5%
on those stocks since Q4 2024
Positions as of Mar 31, 2025, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 35% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2024. Striped tiles are options.
Largest buys
Since Q4 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Broadcom~$2.09BAdded · 2.0% → 1.9%+12,458,783 shares
- Mastercard~$2.06BAdded · 0.9% → 1.4%+3,765,378 shares
- Unitedhealth Group Inc~$1.30BAdded · 2.2% → 2.6%+2,486,839 shares
- Coca Cola Co~$1.17BAdded · 0.4% → 0.7%+16,383,870 shares
- Marsh & Mclennan Cos Inc~$1.10BAdded · 0.3% → 0.6%+4,505,548 shares
- Bristol-Myers Squibb Co~$1.08BAdded · 0.1% → 0.3%+17,750,938 shares
- Schwab Charles Corp~$1.04BAdded · 0.0% → 0.2%+13,262,309 shares
- Bank America Corp~$1.00BAdded · 0.5% → 0.7%+24,042,326 shares
- Qiagen Nv~$972.2MNew · 0.0% → 0.2%+24,438,441 shares
- Sempra~$733.5MAdded · 0.6% → 0.7%+10,278,893 shares
Largest sells
Since Q4 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Alphabet~$1.55BCut · 2.3% → 1.7%−10,049,568 shares
- Apple~$1.51BCut · 4.1% → 3.5%−6,794,618 shares
- Jpmorgan Chase & Co.~$1.34BCut · 1.3% → 1.1%−5,465,035 shares
- General Dynamics Corp~$1.25BCut · 0.4% → 0.2%−4,587,544 shares
- Wells Fargo Co New~$1.17BCut · 1.1% → 1.0%−16,346,369 shares
- Microsoft~$1.13BCut · 4.1% → 3.6%−3,008,079 shares
- Qiagen Nv~$970.5MSold out · 0.2% → 0.0%−21,782,305 shares
- Gilead Sciences Inc~$930.0MCut · 0.6% → 0.6%−8,300,040 shares
- Pfizer Inc~$924.8MCut · 0.7% → 0.5%−36,497,190 shares
- Qualcomm~$798.9MCut · 0.3% → 0.1%−5,201,085 shares
Holdings
As of Mar 31, 2025. Changes are in shares against Dec 31, 2024, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −5.7% · price −10.9% | 3.6% | $18.76B | −$2.30B | ||||||||
| AppleCOM · shares −7.6% · price −11.3% | 3.5% | $18.32B | −$2.33B | ||||||||
| NvidiaCOM · shares −3.5% · price −19.3% | 2.9% | $14.84B | −$3.55B | ||||||||
| Unitedhealth Group IncCOM · shares +11% · price +3.5% | 2.6% | $13.54B | +$417.9M | ||||||||
| AmazonCOM · shares −2.4% · price −13.3% | 2.4% | $12.33B | −$1.89B | ||||||||
| Eli LillyCOM · shares +0.6% · price +7.0% | 2.0% | $10.50B | +$680.7M | ||||||||
| BroadcomCOM · shares +27% · price −27.8% | 1.9% | $9.87B | −$3.00B | ||||||||
| AlphabetCAP STK CL A · shares −15% · price −18.3% | 1.7% | $8.66B | −$1.94B | ||||||||
| MastercardCL A · shares +39% · price +4.1% | 1.4% | $7.41B | +$210.3M | ||||||||
| Merck & Co IncCOM · shares +1.1% · price −9.8% | 1.4% | $7.33B | −$784.8M | ||||||||
| Jpmorgan Chase & Co.COM · shares −19% · price +2.3% | 1.1% | $5.85B | +$133.4M | ||||||||
| MetaCL A · shares +2.5% · price −1.6% | 1.1% | $5.79B | −$89.6M | ||||||||
| Wells Fargo Co NewCOM · shares −19% · price +2.2% | 0.98% | $5.09B | +$110.0M | ||||||||
| American Express CoCOM · shares +14% · price −9.3% | 0.93% | $4.85B | −$439.9M | ||||||||
| Tjx Cos Inc NewCOM · shares −1.1% · price +0.8% | 0.81% | $4.20B | +$34.1M | ||||||||
| NetflixCOM · shares +3.5% · price +4.6% | 0.79% | $4.09B | +$174.6M | ||||||||
| Abbott LabsCOM · shares +13% · price +17.3% | 0.76% | $3.95B | +$515.7M | ||||||||
| Visa Inc.COM CL A · shares +18% · price +10.9% | 0.74% | $3.85B | +$321.1M | ||||||||
| Procter And Gamble CoCOM · shares −8.1% · price +1.7% | 0.73% | $3.79B | +$61.7M | ||||||||
| Johnson & JohnsonCOM · shares −7.0% · price +14.7% | 0.72% | $3.76B | +$480.5M | ||||||||
| Bank America CorpCOM · shares +36% · price −5.1% | 0.72% | $3.75B | −$146.3M | ||||||||
| Accenture Plc IrelandSHS CLASS A · shares −1.5% · price −11.3% | 0.72% | $3.74B | −$476.6M | ||||||||
| Mcdonalds CorpCOM · shares −15% · price +7.8% | 0.71% | $3.70B | +$266.4M | ||||||||
| Danaher CorporationCOM · shares −17% · price −10.7% | 0.70% | $3.63B | −$434.6M | ||||||||
| Texas InstrumentsCOM · shares −6.2% · price −4.2% | 0.68% | $3.52B | −$152.9M | ||||||||
| Total · 1,933 positions | 100% | $519.87B | −$17.31B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2024 to Q1 2025: 1,672 stocks held throughout, down $17.31B (−3.5%).
- Eli Lilly+$680.7M+7%
- Philip Morris Intl Inc+$663.1M+32%
- T-Mobile Us Inc+$580.9M+21%
- Gilead Sciences Inc+$538.4M+21%
- Abbott Labs+$515.7M+17%
- Alphabet−$1.94B−18%
- Microsoft−$2.30B−11%
- Apple−$2.33B−11%
- Broadcom−$3.00B−28%
- Nvidia−$3.55B−19%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |